TrialCancer medicine2023

Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study.

Sujun Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.